XML 41 R31.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stock-Based Compensation (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Jan. 14, 2016
shares
Jun. 02, 2014
Mar. 31, 2016
USD ($)
shares
Mar. 31, 2015
USD ($)
Dec. 31, 2011
shares
Stock-based compensation          
Number of shares of Theravance Biopharma issued for every share of Theravance   0.286      
Stock-based compensation expense | $     $ 1,864 $ 1,933  
Minimum payout of shares (in shares)     0    
Maximum payout of shares (in shares)     328,688    
Market condition based on relative total shareholder return (TSR) And Service condition based on Performance Measures          
Stock-based compensation          
Timeframe for calculation of TSR     2 years    
RSAs | Vesting on February 20, 2018          
Stock-based compensation          
Portion of options vesting (as a percent)     66.70%    
RSAs | Vesting on February 20, 2019          
Stock-based compensation          
Portion of options vesting (as a percent)     33.30%    
RSAs | Market condition based on relative total shareholder return (TSR) And Service condition based on Performance Measures          
Stock-based compensation          
Granted (in shares) 282,394        
RSUs | Vesting on February 20, 2018          
Stock-based compensation          
Portion of options vesting (as a percent)     66.70%    
RSUs | Vesting on November 20, 2018          
Stock-based compensation          
Portion of options vesting (as a percent)     33.30%    
RSUs | Market condition based on relative total shareholder return (TSR) And Service condition based on Performance Measures          
Stock-based compensation          
Granted (in shares) 46,294        
Special Long-Term Retention and Incentive Cash Awards Program | RSAs | Performance-contingent          
Stock-based compensation          
Shares of common stock approved and authorized for issuance         1,290,000
Timeframe for achievement of performance conditions         6 years
Outstanding (in shares)     63,000    
Stock-based compensation expense | $     $ 0